Quantitative electrochemical detection of cathepsin B activity in breast cancer cell lysates using carbon nanofiber nanoelectrode arrays toward identification of cancer formation

2014 Kotaska, 2012, Urine and serum cathepsin B concentrations in the transitional cell carcinoma of the bladder, J Clin Lab Anal, 26, 61, 10.1002/jcla.21483 Sahai, 2005, Mechanisms of cancer cell invasion, Curr Opin Genet Dev, 15, 87, 10.1016/j.gde.2004.12.002 Lee, 2004, Extracellular proteases as targets for treatment of cancer metastases, Chem Soc Rev, 33, 401, 10.1039/b209224g Koblinski, 2000, Unraveling the role of proteases in cancer, Clin Chim Acta, 291, 113, 10.1016/S0009-8981(99)00224-7 Sukoh, 1994, Immunohistochemical study of cathepsin B. Prognostic significance in human lung cancer, Cancer, 74, 46, 10.1002/1097-0142(19940701)74:1<46::AID-CNCR2820740109>3.0.CO;2-G Nouh, 2011, Cathepsin B: a potential prognostic marker for inflammatory breast cancer, J Transl Med, 9, 1, 10.1186/1479-5876-9-1 Mort, 2013, Chapter 406—Cathepsin B, vol. 2, 1784 Barrett, 1981, Cathepsin B, cathepsin H, and cathepsin L, Methods Enzymol, 80, 535, 10.1016/S0076-6879(81)80043-2 Elliott, 1996, The cysteine protease cathepsin B in cancer, Perspect Drug Discov, 6, 12, 10.1007/BF02174043 Chen, 2011, Detection of cathepsin B, cathepsin L, cystatin C, urokinase plasminogen activator and urokinase plasminogen activator receptor in the sera of lung cancer patients, Oncol Lett, 2, 693, 10.3892/ol.2011.302 Buck, 1994, Increased levels of 72 kilodalton type IV collagenase and cathepsin B in microdissected human breast and colon carcinomas, Proc Am Assoc Cancer Res, 35, 59 Emmert-Buck, 1994, Increased gelatinanse A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples, Am J Pathol, 145, 1285 Swisher, 2013, Electrochemical protease biosensor based on enhanced AC voltammetry using carbon nanofiber nanoelectrode arrays, J Phys Chem C, 117, 4268, 10.1021/jp312031u Swisher, 2014, Quantitative electrochemical detection of cathepsin B activity in complex tissue lysates using enhanced AC voltammetry at carbon nanofiber nanoelectrode arrays, Biosens Bioelectron, 56, 129, 10.1016/j.bios.2014.01.002 Syed, 2011, Enhanced electron transfer rates by AC voltammetry for ferrocenes attached to the end of embedded carbon nanofiber nanoelectrode array, Electroanalysis, 23, 1709, 10.1002/elan.201100088 Mandadapu, 2013, Inhibition of norovirus 3CL protease by bisulfite adducts of transition state inhibitors, Bioorg Med Chem Lett, 23, 62, 10.1016/j.bmcl.2012.11.026 Li, 2003, Carbon nanotube nanoelectrode array for ultrasensitive DNA detection, Nano Lett, 3, 597, 10.1021/nl0340677 Li, 2005, Inlaid multi-walled carbon nanotube nanoelectrode arrays for electroanalysis, Electroanalysis, 17, 15, 10.1002/elan.200403114 Siddiqui, 2010, Characterization of carbon nanofiber electrode arrays using electrochemical impedance spectroscopy: effect of scaling down electrode size, ACS Nano, 4, 955, 10.1021/nn901583u Arumugam, 2009, Wafer-scale fabrication of patterned carbon nanofiber nanoelectrode arrays: a route for development of multiplexed, ultrasensitive disposable biosensors, Biosens Bioelectron, 24, 2818, 10.1016/j.bios.2009.02.009 Creager, 1999, Electron transfer at electrodes through conjugated “molecular wire” bridges, J Am Chem Soc, 121, 1059, 10.1021/ja983204c Gutiérrez, 2004, A theoretical approach to some analytical properties of heterogeneous enzymatic assays, Anal Chem, 76, 2664, 10.1021/ac049885d Muss, 1992, Endocrine therapy for advanced breast cancer: a review, Breast Cancer Res Treat, 21, 15, 10.1007/BF01811960 Santen, 1990, Endocrine treatment of breast cancer in women, Endocr Rev, 11, 221, 10.1210/edrv-11-2-221 Lerner, 1990, Development of antiestrogens and their use in breast cancer: eighth Cain memorial award lecture, Cancer Res, 50, 4177 Jordan, 1995, Alternate antiestrogens and approaches to the prevention of breast cancer, J Cell Biochem Suppl, 22, 51, 10.1002/jcb.240590808 Morrow, 1993, Molecular mechanisms of resistance to tamoxifen therapy in breast cancer, Arch Surg, 128, 1187, 10.1001/archsurg.1993.01420230015002 Clark, 1994, Prognostic factors: rationale and methods of analysis and integration, Breast Cancer Res Treat, 32, 105, 10.1007/BF00666211 Ethier, 1995, Growth factor synthesis and human breast cancer progression, J Natl Cancer Inst, 87, 964, 10.1093/jnci/87.13.964 Dickson, 1995, Growth factors in breast cancer, Endocr Rev, 16, 559, 10.1210/edrv-16-5-559 King, 1992, Breast cancer genes: how many, where and who are they?, Nat Genet, 2, 89, 10.1038/ng1092-89 Nägler, 1997, Major increase in endopeptidase activity of human cathepsin B upon removal of occluding loop contacts, Biochemical, 36, 12608, 10.1021/bi971264+ Cotrin, 2004, Positional-scanning combinatorial libraries of fluorescence resonance energy transfer peptides to define substrate specificity of carboxydipeptidases: assays with human cathepsin B, Anal Biochem, 335, 244, 10.1016/j.ab.2004.09.012